Safety and Effectiveness of BOTOX for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Trial Profile

Safety and Effectiveness of BOTOX for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Facial-wrinkles
  • Focus Adverse reactions
  • Sponsors Allergan
  • Most Recent Events

    • 27 Oct 2017 Status changed from recruiting to completed.
    • 23 Jun 2015 Planned End Date changed from 1 Feb 2018 to 1 Nov 2017 as per ClinicalTrials.gov record.
    • 23 Jun 2015 Planned primary completion date changed from 1 Feb 2018 to 1 Nov 2017 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top